Companies / Avanos Medical, Inc.
Avanos Medical, Inc.
Financials · FY2025
Ownership
46.8M shares outstanding · as of Apr 28, 2026
Ownership
| Insiders | 1.19% | 556,809 |
| 10%+ / strategic | 6.83% | 3,200,000 |
| Institutions | 89.36% | 41,843,125 |
| Public float | 2.62% | 1,224,859 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 7
View all →| Insider | % of shares | Shares |
|---|---|---|
Pacitti DavidCEOChief Executive Officer | 0.73% | 343,388 |
Galovan Scott MichaelSVP, Chief Financial Officer | 0.30% | 139,824 |
Delgado SigfridoSVP, Operations | 0.13% | 60,005 |
Hurley John JosephPrincipal Accounting Officer | 0.03% | 13,592 |
Blackford GaryDirector | — | — |
Oleary Patrick JDirector | — | — |
Shimer Julie AnnDirector | — | — |
Institutional holders 278
View all →| Holder | Value | % of shares |
|---|---|---|
| $185.82M | 15.95% | |
| $50.03M | 4.29% | |
| $39.61M | 7.53% | |
| $35.94M | 6.83% | |
| $31.26M | 4.76% | |
| $24.23M | 4.61% | |
| $15.33M | 2.34% | |
| $12.29M | 2.34% | |
| $11.84M | 1.80% | |
| $11.69M | 2.22% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $17.86M | +718K +10.63% | 7,468,794 15.95% of shares | medium |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | Common stock | $-10.06M | -718K -98.11% | 13,826 0.03% of shares | medium |
| Q1 2026 as of | D. E. Shaw & Co., Inc. 13F manager | Trim | Common stock | $-7.55M | -539K -44.53% | 671,413 1.43% of shares | medium |
| Q2 2026 as of | Deutsche Bank AG 13F manager | Trim | Common stock | $-5.46M | -219K -81.93% | 48,369 0.10% of shares | medium |
| Q1 2026 as of | Brown Advisory Inc 13F manager | Add | Common stock | $4.14M | +295K +15.26% | 2,231,198 4.76% of shares | low |
| Q1 2026 as of | Punch & Associates Investment Management, Inc. 13F manager | Add | Common stock | $2.34M | +167K +61.88% | 437,085 0.93% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | Add | Common stock | $1.89M | +79K +446.22% | 96,194 0.21% of shares | low |
| Q1 2026 as of | Deerfield Management Company, L.P. 13F manager | Exit | Common stock | $-1.88M | -167K -100.00% | 0 | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| RGM Capital, LLC | Passive13G/A | — |
| Armistice Capital, LLC | Passive13G/A | — |
| Dimensional Fund Advisors LP | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| AVNS | — | 05350V106 |